Vulnerability Description
In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
CVSS Score
6.7
MEDIUM
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Sophos | Home | <= 10.0.3 |
| Sophos | Intercept X | <= 9.10.1 |
References
- https://community.sophos.com/b/security-blogVendor Advisory
- https://community.sophos.com/b/security-blog/posts/resolved-lpe-in-endpoint-for-Vendor Advisory
- https://community.sophos.com/b/security-blogVendor Advisory
- https://community.sophos.com/b/security-blog/posts/resolved-lpe-in-endpoint-for-Vendor Advisory
FAQ
What is CVE-2021-25264?
CVE-2021-25264 is a vulnerability with a CVSS score of 6.7 (MEDIUM). In multiple versions of Sophos Endpoint products for MacOS, a local attacker could execute arbitrary code with administrator privileges.
How severe is CVE-2021-25264?
CVE-2021-25264 has been rated MEDIUM with a CVSS base score of 6.7/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2021-25264?
Check the references section above for vendor advisories and patch information. Affected products include: Sophos Home, Sophos Intercept X.